No Cover Image

Journal article 186 views

Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma

Jedd D. Wolchok, Vanna Chiarion-Sileni, Piotr Rutkowski, C. Lance Cowey, Dirk Schadendorf Orcid Logo, John Wagstaff, Paola Queirolo, Reinhard Dummer, Marcus O. Butler, Andrew G. Hill, Michael A. Postow Orcid Logo, Caroline Gaudy-Marqueste, Theresa Medina, Christopher D. Lao, John Walker, Iván Márquez-Rodas, John B.A.G. Haanen, Massimo Guidoboni, Michele Maio, Patrick Schöffski, Matteo S. Carlino, Shahneen Sandhu, Céleste Lebbé, Paolo A. Ascierto Orcid Logo, Georgina V. Long Orcid Logo, Corey Ritchings, Ayman Nassar, Margarita Askelson, Melanie Pe Benito, Wenjia Wang, F. Stephen Hodi, James Larkin

New England Journal of Medicine, Volume: 392, Issue: 1, Pages: 11 - 22

Swansea University Author: John Wagstaff

Full text not available from this repository: check for access using links below.

Check full text

DOI (Published version): 10.1056/nejmoa2407417

Published in: New England Journal of Medicine
ISSN: 0028-4793 1533-4406
Published: Massachusetts Medical Society 2025
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa69784
first_indexed 2025-06-20T13:54:14Z
last_indexed 2025-07-22T05:04:03Z
id cronfa69784
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2025-07-21T10:54:24.1738499</datestamp><bib-version>v2</bib-version><id>69784</id><entry>2025-06-20</entry><title>Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma</title><swanseaauthors><author><sid>fdab5e9e2fe06c93d3ffa19c816bdcf6</sid><firstname>John</firstname><surname>Wagstaff</surname><name>John Wagstaff</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2025-06-20</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>New England Journal of Medicine</journal><volume>392</volume><journalNumber>1</journalNumber><paginationStart>11</paginationStart><paginationEnd>22</paginationEnd><publisher>Massachusetts Medical Society</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0028-4793</issnPrint><issnElectronic>1533-4406</issnElectronic><keywords/><publishedDay>2</publishedDay><publishedMonth>1</publishedMonth><publishedYear>2025</publishedYear><publishedDate>2025-01-02</publishedDate><doi>10.1056/nejmoa2407417</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm>Not Required</apcterm><funders/><projectreference/><lastEdited>2025-07-21T10:54:24.1738499</lastEdited><Created>2025-06-20T14:49:39.2094064</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Biomedical Science</level></path><authors><author><firstname>Jedd D.</firstname><surname>Wolchok</surname><order>1</order></author><author><firstname>Vanna</firstname><surname>Chiarion-Sileni</surname><order>2</order></author><author><firstname>Piotr</firstname><surname>Rutkowski</surname><order>3</order></author><author><firstname>C. Lance</firstname><surname>Cowey</surname><order>4</order></author><author><firstname>Dirk</firstname><surname>Schadendorf</surname><orcid>0000-0003-3524-7858</orcid><order>5</order></author><author><firstname>John</firstname><surname>Wagstaff</surname><order>6</order></author><author><firstname>Paola</firstname><surname>Queirolo</surname><order>7</order></author><author><firstname>Reinhard</firstname><surname>Dummer</surname><order>8</order></author><author><firstname>Marcus O.</firstname><surname>Butler</surname><order>9</order></author><author><firstname>Andrew G.</firstname><surname>Hill</surname><order>10</order></author><author><firstname>Michael A.</firstname><surname>Postow</surname><orcid>0000-0002-3367-7961</orcid><order>11</order></author><author><firstname>Caroline</firstname><surname>Gaudy-Marqueste</surname><order>12</order></author><author><firstname>Theresa</firstname><surname>Medina</surname><order>13</order></author><author><firstname>Christopher D.</firstname><surname>Lao</surname><order>14</order></author><author><firstname>John</firstname><surname>Walker</surname><order>15</order></author><author><firstname>Iv&#xE1;n</firstname><surname>M&#xE1;rquez-Rodas</surname><order>16</order></author><author><firstname>John B.A.G.</firstname><surname>Haanen</surname><order>17</order></author><author><firstname>Massimo</firstname><surname>Guidoboni</surname><order>18</order></author><author><firstname>Michele</firstname><surname>Maio</surname><order>19</order></author><author><firstname>Patrick</firstname><surname>Sch&#xF6;ffski</surname><order>20</order></author><author><firstname>Matteo S.</firstname><surname>Carlino</surname><order>21</order></author><author><firstname>Shahneen</firstname><surname>Sandhu</surname><order>22</order></author><author><firstname>C&#xE9;leste</firstname><surname>Lebb&#xE9;</surname><order>23</order></author><author><firstname>Paolo A.</firstname><surname>Ascierto</surname><orcid>0000-0002-8322-475X</orcid><order>24</order></author><author><firstname>Georgina V.</firstname><surname>Long</surname><orcid>0000-0001-8894-3545</orcid><order>25</order></author><author><firstname>Corey</firstname><surname>Ritchings</surname><order>26</order></author><author><firstname>Ayman</firstname><surname>Nassar</surname><order>27</order></author><author><firstname>Margarita</firstname><surname>Askelson</surname><order>28</order></author><author><firstname>Melanie Pe</firstname><surname>Benito</surname><order>29</order></author><author><firstname>Wenjia</firstname><surname>Wang</surname><order>30</order></author><author><firstname>F. Stephen</firstname><surname>Hodi</surname><order>31</order></author><author><firstname>James</firstname><surname>Larkin</surname><order>32</order></author></authors><documents/><OutputDurs/></rfc1807>
spelling 2025-07-21T10:54:24.1738499 v2 69784 2025-06-20 Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma fdab5e9e2fe06c93d3ffa19c816bdcf6 John Wagstaff John Wagstaff true false 2025-06-20 MEDS Journal Article New England Journal of Medicine 392 1 11 22 Massachusetts Medical Society 0028-4793 1533-4406 2 1 2025 2025-01-02 10.1056/nejmoa2407417 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University Not Required 2025-07-21T10:54:24.1738499 2025-06-20T14:49:39.2094064 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Biomedical Science Jedd D. Wolchok 1 Vanna Chiarion-Sileni 2 Piotr Rutkowski 3 C. Lance Cowey 4 Dirk Schadendorf 0000-0003-3524-7858 5 John Wagstaff 6 Paola Queirolo 7 Reinhard Dummer 8 Marcus O. Butler 9 Andrew G. Hill 10 Michael A. Postow 0000-0002-3367-7961 11 Caroline Gaudy-Marqueste 12 Theresa Medina 13 Christopher D. Lao 14 John Walker 15 Iván Márquez-Rodas 16 John B.A.G. Haanen 17 Massimo Guidoboni 18 Michele Maio 19 Patrick Schöffski 20 Matteo S. Carlino 21 Shahneen Sandhu 22 Céleste Lebbé 23 Paolo A. Ascierto 0000-0002-8322-475X 24 Georgina V. Long 0000-0001-8894-3545 25 Corey Ritchings 26 Ayman Nassar 27 Margarita Askelson 28 Melanie Pe Benito 29 Wenjia Wang 30 F. Stephen Hodi 31 James Larkin 32
title Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
spellingShingle Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
John Wagstaff
title_short Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
title_full Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
title_fullStr Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
title_full_unstemmed Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
title_sort Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
author_id_str_mv fdab5e9e2fe06c93d3ffa19c816bdcf6
author_id_fullname_str_mv fdab5e9e2fe06c93d3ffa19c816bdcf6_***_John Wagstaff
author John Wagstaff
author2 Jedd D. Wolchok
Vanna Chiarion-Sileni
Piotr Rutkowski
C. Lance Cowey
Dirk Schadendorf
John Wagstaff
Paola Queirolo
Reinhard Dummer
Marcus O. Butler
Andrew G. Hill
Michael A. Postow
Caroline Gaudy-Marqueste
Theresa Medina
Christopher D. Lao
John Walker
Iván Márquez-Rodas
John B.A.G. Haanen
Massimo Guidoboni
Michele Maio
Patrick Schöffski
Matteo S. Carlino
Shahneen Sandhu
Céleste Lebbé
Paolo A. Ascierto
Georgina V. Long
Corey Ritchings
Ayman Nassar
Margarita Askelson
Melanie Pe Benito
Wenjia Wang
F. Stephen Hodi
James Larkin
format Journal article
container_title New England Journal of Medicine
container_volume 392
container_issue 1
container_start_page 11
publishDate 2025
institution Swansea University
issn 0028-4793
1533-4406
doi_str_mv 10.1056/nejmoa2407417
publisher Massachusetts Medical Society
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Biomedical Science{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Biomedical Science
document_store_str 0
active_str 0
published_date 2025-01-02T05:27:52Z
_version_ 1851369636038180864
score 11.089572